Dihydrodipicolinate synthase (DHDPS) catalyses the rate-limiting step in the biosynthesis of meso-diaminopimelate and lysine. Here, the cloning, expression, purification and crystallization of DHDPS from the intracellular pathogen Legionella pneumophila are described. Crystals grown in the presence of highmolecular-weight PEG precipitant and magnesium chloride were found to diffract beyond 1.65 Å resolution. The crystal lattice belonged to the hexagonal space group P6 1 22, with unit-cell parameters a = b = 89.31, c = 290.18 Å , and contained two molecules in the asymmetric unit. The crystal structure was determined by molecular replacement using a single chain of Pseudomonas aeruginosa DHDPS as the search model.
Introduction
Dihydrodipicolinate synthase (DHDPS) functions as a key enzyme in the diaminopimelate (DAP) pathway of bacteria, plants and some fungi (Hutton et al., 2007; Dogovski et al., 2009 Dogovski et al., , 2012 . In bacteria, the pathway yields two metabolites important to bacterial survival (Kobayashi et al., 2003) , namely meso-diaminopimelate (meso-DAP) and lysine. meso-DAP is a key component of the peptidoglycan layer in the bacterial cell wall and lysine is a fundamental building block of housekeeping proteins and bacterial virulence factors (Schleifer & Kandler, 1972; Dogovski et al., 2009 Dogovski et al., , 2012 . As a consequence, enzymes of the DAP pathway are promising antibiotic targets (Hutton et al., 2007; Dogovski et al., 2009 Dogovski et al., , 2012 . In addition, lysine is one of the essential amino acids in the human diet and as such offers a potential avenue for the design of inhibitors to this pathway with low host toxicity (Hutton et al., 2007; Dogovski et al., 2009 Dogovski et al., , 2012 .
The first committed step in the synthesis of meso-DAP and lysine involves aldol condensation of pyruvate and (S)-aspartate semialdehyde (ASA) to form (4S)-4-hydroxy-2,3,4,5-tetrahydro-(2S)-dipicolinic acid (Blickling, Renner et al., 1997; Hutton et al., 2007; Dogovski et al., 2009 Dogovski et al., , 2012 . This rate-limiting step is catalysed by the enzyme DHDPS. In all Gram-negative pathogens (Dobson, Devenish et al., 2005; Phenix & Palmer, 2008; Devenish et al., 2009; Kaur et al., 2011) and plants (Matthews & Widholm, 1979; Wallsgrove & Mazelis, 1980; Kumpaisal et al., 1987; Dereppe et al., 1992; Blickling, Beisel et al., 1997; Griffin et al., 2012; Atkinson et al., 2013) studied to date, lysine acts as a feedback inhibitor to DHDPS.
The structure of DHDPS has been investigated in several bacteria including Agrobacterium tumefaciens , Bacillus anthracis (Blagova et al., 2006; Voss et al., 2009 Voss et al., , 2010 , Clostridium botulinum , Corynebacterium glutamicum (Rice et al., 2008) , Escherichia coli (Mirwaldt et al., 1995; Dobson, Griffin et al., 2005) , Hahella chejuensis (Kang et al., 2010) , Methanococcus jannaschii (Padmanabhan et al., 2009) , Mycobacterium tuberculosis (Kefala et al., 2008; Evans et al., 2011) , Neisseria meningitidis (Devenish et al., 2009) , Pseudomonas aeruginosa (Kaur et al., 2011) , Shewenella benthica (Wubben et al., 2010) , Staphylococcus aureus (Burgess et al., 2008; Girish et al., 2008) , Streptococcus pneumoniae (Sibarani et al., 2010) and Thermotoga maritima (Pearce et al., 2006) . The enzyme typically forms a homotetramer that is described as a dimer of dimers. In this arrangement, two monomers associate to create a dimer at the 'tight-dimer' interface (Perugini et al., 2005; Griffin et al., 2008 Griffin et al., , 2010 . Two such dimers then unite to create a tetramer via interactions at the 'weak-dimer' interface where weaker bonding interactions exist (Perugini et al., 2005; Griffin et al., 2008 Griffin et al., , 2010 . Recently, homodimers and dimeric mutants of DHDPS have also surfaced that exhibit high levels of activity (Burgess et al., 2008; Girish et al., 2008; Wubben et al., 2010; Evans et al., 2011; Kaur et al., 2011) .
Despite different quaternary states, the DHDPS monomer remains a (/) 8 -barrel in which the active site is located central to the barrel (Mirwaldt et al., 1995) . This gives rise to four active sites in a tetrameric DHDPS or two active sites in a dimeric DHDPS (Mirwaldt et al., 1995) . Adjacent to the active sites is a cleft at the tight-dimer interface to which lysine binds in order to inhibit the enzyme (Dobson, Griffin et al., 2005; Kaur et al., 2011; Griffin et al., 2012; Atkinson et al., 2013) .
Whilst DHDPS has been extensively studied in extracellular bacterial species, there have been no published data on DHDPS from intracellular bacteria. Investigating DHDPS from an intracellular species will provide greater insight into the structure, function and inhibition of this enzyme. Furthermore, it will enable discovery of inhibitors appropriate for penetration into host cells.
To develop our understanding in this area, the work outlined here describes the cloning, expression, purification, crystallization and preliminary X-ray crystallographic data of DHDPS from the intracellular human pathogen Legionella pneumophila (Lp-DHDPS). L. pneumophila is a Gram-negative bacterium that invades and replicates within a broad range of hosts extending from protozoa to human alveolar macrophages (Rowbotham, 1980; Fields, 1996) . Upon entering the human body, it causes the often fatal pneumonia called Legionnaires' disease. Its major source of carbon and energy come from amino acids scavenged from the host cell (Warren & Miller, 1979; George et al., 1980; Tesh & Miller, 1981; Tesh et al., 1983; Sauer et al., 2005) . Interestingly, DAP pathway genes have been annotated and shown to be expressed in L. pneumophila (Brü ggemann et al., 2006; Faucher et al., 2011) , suggesting that the pathway is important for survival in this bacterium.
Previous attempts at crystallizing the apo form of this enzyme resulted in crystals with poor diffraction. Reports of the pyruvatestabilization phenomenon (Blickling, Renner et al.,1997; Burgess et al., 2008; Voss et al., 2010; Atkinson et al., 2009 ) prompted cocrystallization of Lp-DHDPS with pyruvate. Diffraction was found to significantly improve with the substrate-bound form of the enzyme.
Materials and methods

Cloning the gene encoding dihydrodipicolinate synthase from L. pneumophila
The dapA gene, which encodes DHDPS, was PCR-amplified using L. pneumophila genomic DNA and the primer pair F1 (5 0 -GCTGATAGAGATTCCGGTTG-3 0 ) and R1 (5 0 -GCTTCGCCAT-TACGGCTCTG-3 0 ). The amplified product was cloned into the pCR-Blunt II-TOPO shuttle vector (Invitrogen) to create the plasmid pTS01. dapA was subsequently amplified from pTS01 using the primer pair F2 (5 0 -CATATGTTCAGTGGAAGTATAGTA-3 0 ) and R2 (5 0 -GGATCCTTATATCAACTCTAAATTCTTC-3 0 ). The design of these primers allowed the incorporation of NdeI and BamHI restriction sites upstream and downstream, respectively, of the open reading frame. The resulting product was ligated between NdeI and BamHI restriction sites of pET11a (Novagen) to create the expression vector pET-LpS. The identity of the dapA gene from L. pneumophila was confirmed by restriction analysis and dideoxynucleotide sequencing.
Expression and purification of L. pneumophila DHDPS
E. coli BL21-DE3 cells (Stratagene) harbouring pET-LpS were cultivated in 1 l Luria broth containing 75 mg ml À1 ampicillin. Cells were incubated at 310 K with shaking at 180 oscillations per minute (OPM) to an OD 600 nm of 0.4 and were subsequently transferred to 289 K until the cultures attained an OD 600 nm of 0.7. Cells were treated with 1.0 mM isopropyl -d-1-thiogalactopyranoside to induce recombinant protein production at 289 K and were subsequently harvested 16 h post-induction by centrifugation (10 000g at 277 K for 20 min). Cell pellets were resuspended in 11 ml buffer A (20 mM Tris, 5 mM pyruvate pH 7.5) and then lysed using a Misonix S-4000 sonicator (20 s bursts at 40 m followed by 40 s rest periods for 10 min). The cell lysate was centrifuged (20 000g at 277 K for 20 min) to pellet cellular debris and the resulting supernatant was further clarified by filtration using a 0.45 mm syringe filter (Millipore).
Recombinant Lp-DHDPS was purified using a two-step strategy that involved anion-exchange and hydrophobic interaction chromatography. Briefly, lysate was applied onto a Q Sepharose column (bed volume 60 ml; 26 mm diameter Â 10 cm length; GE Healthcare) preequilibrated with buffer A at 277 K. The column was washed in buffer A at 3 ml min À1 until a steady absorbance baseline (A 280 nm ) was achieved. To elute protein, a two-step gradient was applied. The first involved a gradient of 100-40% buffer A:0-60% buffer B (20 mM Tris, 5 mM pyruvate, 1 M NaCl pH 7.5) over 10 column volumes (CV). Secondly, a gradient of 40-0% buffer A:60-100% buffer B over 1 CV was applied. Lp-DHDPS eluted at approximately 0.3 M NaCl. Peak fractions were pooled and prior to performing hydrophobic interaction chromatography, ammonium sulfate was added to a final concentration of 1 M. Pooled fractions were subsequently injected onto a Phenyl Sepharose column (bed volume 60 ml; 26 mm diameter Â 10 cm length; GE Healthcare) pre-equilibrated with buffer C (20 mM Tris, 5 mM pyruvate, 1 M ammonium sulfate pH 7.5) at 277 K. The column was washed in buffer C at 3 ml min À1 until a steady absorbance baseline (A 280 nm ) was attained. A two-step gradient allowed further purification of Lp-DHDPS. Firstly, a gradient of 100-50% buffer C:0-50% buffer A was applied over 2 CV. This was followed by a gradient of 50-0% buffer C:50-100% buffer A over 8 CV. Peak fractions were pooled and dialysed in buffer D (20 mM Tris, 5 mM pyruvate, 150 mM NaCl pH 7.5) overnight. Thereafter, the dialysed sample was separated into 1.5 ml aliquots and flash-cooled before storage at 193 K. Prior to crystallization trials, protein was thawed overnight at 277 K and concentrated using a 10 000 MWCO Amicon filter (Millipore). Size-exclusion chromatography was performed in buffer D using a Superose 12 column (bed volume 24 ml; 10 mm diameter Â 30 cm length; GE Healthcare) to remove aggregates, followed again by concentrating the protein using a 10 000 MWCO Amicon filter (Millipore) for crystallization. Protein samples were quantified by UV-Vis spectrophotometry using an extinction coefficient at 280 nm of 19 940 M À1 cm À1 .
Mass spectrometry
Electrospray ionization mass spectrometry (ESI-MS) was employed to accurately determine the mass of recombinant Lp-DHDPS. Protein was prepared at a concentration of 0.15 mg ml À1 in 20 mM Tris pH 7.5. Mass data were collected using a micrOTOF-Q mass spectrometer (Bruker Daltonics, Germany) coupled to an UltiMate 3000 RSLCnano system (Dionex, Holland) as described previously (Brand et al., 2012) . Data were annotated and deconvocrystallization communications luted using the DataAnalysis program (Version 4.0, Bruker Daltonics).
Protein crystallization
Initial trials were performed at the CSIRO node of the Bio21 Collaborative Crystallization Centre (C3; http://www.csiro.au/c3/) using the PACT Suite and JCSG+ Suite screens (Qiagen; Newman et al., 2005) . 96-well plates were established at 281 and 293 K using the sitting-drop vapour-diffusion method. Each well contained 150 nl reservoir solution and 150 nl recombinant enzyme solution (10 mg ml À1 ) with pyruvate (5 mM final concentration). Conditions yielding promising crystals were replicated on a larger scale and further screened using the hanging-drop vapour-diffusion method. Drops contained 2 ml protein solution and 2 ml reservoir solution. Each drop varied in pH, polyethylene glycol (PEG) concentration or protein concentration and plates were incubated at 281 and 293 K. The best diffracting crystal was produced at 281 K in reservoir solution consisting of 0.2 M magnesium chloride, 10%(w/v) PEG 8000, 0.1 M Tris chloride pH 10 with protein concentration at 11 mg ml À1 .
Data collection and processing
To prepare the crystal for X-ray data collection, it was briefly soaked in reservoir solution containing 20%(v/v) 2-methyl-2,4-pentanediol and directly flash-cooled in liquid nitrogen. Intensity data were collected at 110 K using the MX2 Micro Crystallography 03ID1 source and the Blu-Ice control software (McPhillips et al., 2002) at the Australian Synchrotron. Data were collected as one 360 pass with 0.5 oscillations using an ADSC Quantum 315r detector positioned 200 mm from the crystal. The exposure time was 1 s with 80% attenuation. Indexing and integration of the data were performed using the program iMOSFLM (Battye et al., 2011) . POINTLESS (Evans, 2006) from the CCP4 program suite (Winn et al., 2011) was used to verify the space group. Scaling, data reduction and truncation of the data were performed using the program SCALA (Evans, 2006) also from the CCP4 suite.
Results and discussion
Recombinant Lp-DHDPS was expressed and purified as outlined in x2. Lane 2 in Fig. 1 represents crude lysate before injection onto a Q Sepharose column. Recombinant Lp-DHDPS is indistinguishable in this sample owing to a high content of cellular proteins. However, removal of such proteins upon anion-exchange reveals the presence of a densely stained band at an apparent molecular weight of 31 kDa (Fig. 1, lane 3) . Remaining contaminants were removed after hydrophobic interaction chromatography (Fig. 1, lane 4) to yield approximately 6 mg of protein per litre of culture and >95% purity as estimated by SDS-PAGE. Mass spectrometry confirmed the identity of this sample to be Lp-DHDPS, with a major peak existing at 31 580.4 Da in the deconvoluted mass spectrum (Fig. 2) . This is Electrospray ionization mass spectrometry analysis of purified recombinant Lp-DHDPS. The deconvoluted mass spectrum reveals a predominant peak at 31 580.4 Da consistent with the expected mass of Lp-DHDPS. Inset: raw mass-tocharge data showing multiple charge states of the protein. consistent with the expected molecular mass of Lp-DHDPS from the amino-acid sequence.
Crystallization screens were then performed with an initial protein concentration of 10 mg ml À1 that yielded crystals in several conditions from the PACT and JCSG+ screens. Crystal growth was typically observed after 3 d and frequently in conditions with PEG and chloride salt. Promising conditions were replicated in-house and produced crystals ranging between 0.05 and 0.40 mm in the longest dimension.
Favourable diffraction data to beyond 1.65 Å resolution (Fig. 3b ) were collected on a crystal from reservoir solution consisting of 0.2 M magnesium chloride, 10%(w/v) PEG 8000, 0.1 M Tris chloride pH 10 (Fig. 3a) . Integration and scaling of the data by XDS (Kabsch, 2010) and iMOSFLM indicated that the crystal lattice belonged to space group P6 1 22, with unit-cell parameters a = b = 89.31, c = 290.18 Å , = = 90.0, = 120.0 . The Matthews coefficient (Matthews, 1968 ) was 2.64 Å 3 Da À1 , with an estimated solvent content of 53.52% for two monomers in the asymmetric unit. Only the first 129 images (64.5 ) out of 720 were processed and scaled given that the remaining images contained significant radiation damage. Scaling and merging of the crystallographic data resulted in an overall R merge of 0.108 with an R merge of 0.343 in the highest resolution shell. Complete datacollection and processing statistics are summarized in Table 1 . The structure of Lp-DHDPS was determined by molecular replacement using chain A of P. aeruginosa DHDPS (PDB entry 3qze; R. Schnell, T. Sandalova & G. Schneider, unpublished work) as the search model, which shares 54% sequence identity with Lp-DHDPS. The structure was solved using Phaser (McCoy et al., 2007) employing two copies of the P. aeruginosa DHDPS model. The solution gave a translationfunction Z score of 29.9 with a final log-likelihood gain of 1400. The first round of refinement gave an R free of 29.1% and an R factor of 26.9%. Further model building and refinement of the structure are in progress.
